TY  - GEN
AU  - Ang,Celina
AU  - Miura,John T
AU  - Gamblin,T Clark
AU  - He,Ruth
AU  - Xiu,Joanne
AU  - Millis,Sherri Z
AU  - Gatalica,Zoran
AU  - Reddy,Sandeep K
AU  - Yee,Nelson S
AU  - Abou-Alfa,Ghassan K
TI  - Comprehensive multiplatform biomarker analysis of 350 hepatocellular carcinomas identifies potential novel therapeutic options
SN  - 1096-9098
PY  - 2016///0530
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antineoplastic Agents
KW  - pharmacology
KW  - Biomarkers, Tumor
KW  - analysis
KW  - Carcinoma, Hepatocellular
KW  - chemistry
KW  - Erlotinib Hydrochloride
KW  - administration & dosage
KW  - Female
KW  - Gene Expression Profiling
KW  - Gene Expression Regulation, Neoplastic
KW  - Humans
KW  - Immunohistochemistry
KW  - Liver Neoplasms
KW  - Lung Neoplasms
KW  - secondary
KW  - Male
KW  - Middle Aged
KW  - Molecular Targeted Therapy
KW  - Mutation
KW  - Niacinamide
KW  - Phenylurea Compounds
KW  - Phosphoinositide-3 Kinase Inhibitors
KW  - Poly(ADP-ribose) Polymerase Inhibitors
KW  - Protein-Tyrosine Kinases
KW  - antagonists & inhibitors
KW  - Retrospective Studies
KW  - Sorafenib
KW  - Tumor Suppressor Protein p53
KW  - genetics
KW  - beta Catenin
N1  - Publication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1002/jso.24086
ER  -